New Hepatitis Meds Are Saving Lives: Study
TUESDAY, Feb. 12, 2019 (HealthDay News) — New (and pricey) hepatitis C medicines, such as Harvoni and Sovaldi, are living up to their promise and greatly reducing patients’ odds for liver cancer and death, a new French study finds. The news came as little surprise to one U.S. liver expert.Continue Reading









